Table 1.
Trial number | Study centre | Study type | Enrolment | Donor group | Primary endpoint | Comment |
NCT03124641 (present trial) | RWTH Aachen University, Aachen, Germany | RCT | 46 | ECD-DBD | Early graft function (peak ALT level) | Recruiting |
NCT01317342 | University of Zurich, Zurich, Switzerland | RCT | 170* | DBD (ECD subgroup analysis only) |
Major postoperative complications (Clavien grade≥III) and CCI* | Recruiting |
NCT02584283 | University of Groningen, Groningen, Netherlands | RCT | 156 | DCD (Maastricht category III) |
Incidence of symptomatic NAS | Recruiting |
*Information based on personal communication.
ALT, alanine aminotransferase; CCI, comprehensive complication index; DBD, donation of the brain death; DCD, donation of the cardiac death; ECD, extended criteria donation; HOPE, hypothermic oxygenated machine perfusion; NAS, non-anastomotic biliary strictures; OLT, orthotopic liver transplantation; RCT, randomised controlled trial; RWTH, Rheinisch-Westfälische Technische Hochschule.